Diagnostic Test & Biomarker Research
Research into diagnostic tests, biomarkers, imaging modalities, liquid biopsies, and laboratory panels for disease evaluation, staging, and treatment monitoring. Focused on identifying the most informative tests for each clinical scenario.
Key Mechanisms
- Circulating biomarker detection and quantification
- Advanced imaging for disease staging
- Genetic and genomic profiling panels
- Liquid biopsy ctDNA and exosome analysis
- Functional assay development
Notable Compounds
- Gadolinium (MRI contrast)
- 18F-FDG (PET tracer)
- Technetium-99m (SPECT)
- Indocyanine green (fluorescence)
- Ferumoxytol (iron oxide nanoparticles)
Disease-Specific Research
- Diagnostic Test & Biomarker Research for ALS (Amyotrophic Lateral Sclerosis)
- Diagnostic Test & Biomarker Research for Stage IV Cancer
- Diagnostic Test & Biomarker Research for Alzheimer's Disease
- Diagnostic Test & Biomarker Research for Parkinson's Disease
- Diagnostic Test & Biomarker Research for Autoimmune Diseases